Australia markets open in 12 minutes

GSK plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
36.33-0.30 (-0.82%)
At close: 04:00PM EST
36.22 -0.11 (-0.30%)
After hours: 05:16PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 76.13B
Enterprise value 94.12B
Trailing P/E 9.73
Forward P/E 9.15
PEG ratio (5-yr expected) 0.96
Price/sales (ttm)1.99
Price/book (mrq)4.51
Enterprise value/revenue 3.17
Enterprise value/EBITDA 9.78

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 3-3.40%
S&P500 52-week change 315.95%
52-week high 339.74
52-week low 333.20
50-day moving average 335.77
200-day moving average 335.51

Share statistics

Avg vol (3-month) 33.71M
Avg vol (10-day) 32.42M
Shares outstanding 52.06B
Implied shares outstanding 62.11B
Float 83.93B
% held by insiders 10.05%
% held by institutions 113.60%
Shares short (14 Nov 2023) 44M
Short ratio (14 Nov 2023) 40.96
Short % of float (14 Nov 2023) 4N/A
Short % of shares outstanding (14 Nov 2023) 40.18%
Shares short (prior month 12 Oct 2023) 44.84M

Dividends & splits

Forward annual dividend rate 41.4
Forward annual dividend yield 43.83%
Trailing annual dividend rate 30.56
Trailing annual dividend yield 31.52%
5-year average dividend yield 45.09
Payout ratio 438.45%
Dividend date 310 Jan 2024
Ex-dividend date 415 Nov 2023
Last split factor 21226:1000
Last split date 321 July 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023

Profitability

Profit margin 20.48%
Operating margin (ttm)31.37%

Management effectiveness

Return on assets (ttm)7.90%
Return on equity (ttm)61.26%

Income statement

Revenue (ttm)29.65B
Revenue per share (ttm)14.66
Quarterly revenue growth (yoy)4.10%
Gross profit (ttm)19.92B
EBITDA 9.19B
Net income avi to common (ttm)6.08B
Diluted EPS (ttm)3.77
Quarterly earnings growth (yoy)-86.50%

Balance sheet

Total cash (mrq)6.68B
Total cash per share (mrq)1.65
Total debt (mrq)20.84B
Total debt/equity (mrq)165.16%
Current ratio (mrq)0.95
Book value per share (mrq)3.24

Cash flow statement

Operating cash flow (ttm)5.48B
Levered free cash flow (ttm)1.86B